Presented by the National Cancer Institute and the Trans-Institute Angiogenesis Research Program Location: Bethesda, MD, NIH Campus, Building 10, Lipsett Auditorium To encourage and facilitate the study of the underlying mechanisms controlling blood vessel growth and development. To identify specific targets and to develop therapeutics against pathologic angiogenesis in order to reduce the morbidity due to abnormal blood vessel proliferation in a variety of disease states. To better understand the process of angiogenesis and vascularization to improve states of decreased vascularization. To encourage and facilitate the study of the processes of lymphangiogenesis. To achieve these goals through a multidisciplinary approach, bringing together investigators with varied backgrounds and varied interests. |
Home | Contact | Privacy Notice | Accessibility |